Activating HSP72 in rodent skeletal muscle increases mitochondrial number and oxidative capacity and decreases insulin resistance

Diabetes

Volumn 63, Issue 6, 2014, Pages 1881-1894

  Henstridge, Darren C ^a   Bruce, Clinton R ^a,b   Drew, Brian G ^c   Tory, Kálmán ^d   Kolonics, Attila ^d   Estevez, Emma ^a   Chung, Jason ^a   Watson, Nadine ^a   Gardner, Timothy ^a   Lee Young, Robert S ^a   Connor, Timothy ^e   Watt, Matthew J ^b   Carpenter, Kevin ^f   Hargreaves, Mark ^g   McGee, Sean L ^e   Hevener, Andrea L ^c   Febbraio, Mark A ^a,d  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d N Gene Research Laboratories   (Hungary)

^e DEAKIN UNIVERSITY   (Australia)

^f UNIVERSITY OF SYDNEY   (Australia)

^g UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CERAMIDE; DIACYLGLYCEROL; FATTY ACID TRANSPORTER; GLUCOSE; HEAT SHOCK PROTEIN 72; INSULIN; O (2 HYDROXY 3 PIPERIDINOPROPYL)NICOTINIC AMIDOXIME; SIRTUIN 1; TRIACYLGLYCEROL;

AEROBIC METABOLISM; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CALORIC INTAKE; CALORIMETRY; CONTROLLED STUDY; ENDURANCE TRAINING; ENERGY METABOLISM; ENZYME ACTIVITY; EPIDIDYMIS FAT; EXERCISE TEST; FATTY ACID OXIDATION; GENE OVEREXPRESSION; GENOTYPE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID DIET; LIPID STORAGE; MALE; MOUSE; MUSCLE METABOLISM; MUSCLE MITOCHONDRION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; RAT MODEL; RUNNING; SKELETAL MUSCLE; UPREGULATION; WILD TYPE;

AMP-ACTIVATED PROTEIN KINASES; ANIMALS; BLOOD GLUCOSE; BLOTTING, WESTERN; BODY WEIGHT; CELL RESPIRATION; DIABETES MELLITUS, TYPE 2; DIET, HIGH-FAT; ENERGY METABOLISM; FATTY ACIDS; HSP72 HEAT-SHOCK PROTEINS; INSULIN RESISTANCE; LEPTIN; MALE; MICE; MITOCHONDRIA, MUSCLE; MUSCLE, SKELETAL; OBESITY; OXIDATION-REDUCTION; OXIDATIVE PHOSPHORYLATION; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS; RATS; REAL-TIME POLYMERASE CHAIN REACTION; SIRTUIN 1;

EID: 84901376570     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db13-0967     Document Type: Article

References (56)

1. Savage DB, Petersen KF, Shulman GI. Disordered lipid metabolism and the pathogenesis of insulin resistance. Physiol Rev 2007;87:507-520
2. Chibalin AV, Leng Y, Vieira E, et al. Downregulation of diacylglycerol kinase delta contributes to hyperglycemia-induced insulin resistance. Cell 2008;132: 375-386
3. Yu C, Chen Y, Cline GW, et al. Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 (IRS-1)-associated phosphatidylinositol 3-kinase activity in muscle. J Biol Chem 2002;277:50230-50236
4. Holland WL, Brozinick JT, Wang LP, et al. Inhibition of ceramide synthesis ameliorates glucocorticoid-, saturated-fat-, and obesity-induced insulin resistance. Cell Metab 2007;5:167-179
5. Morino K, Petersen KF, Shulman GI. Molecular mechanisms of insulin resistance in humans and their potential links with mitochondrial dysfunction. Diabetes 2006;55(Suppl 2):S9-S15
6. Mootha VK, Lindgren CM, Eriksson KF, et al. PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet 2003;34:267-273
7. Patti ME, Butte AJ, Crunkhorn S, et al. Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: Potential role of PGC1 and NRF1. Proc Natl Acad Sci U S A 2003;100:8466-8471
8. Petersen KF, Befroy D, Dufour S, et al. Mitochondrial dysfunction in the elderly: possible role in insulin resistance. Science 2003;300:1140-1142
9. Petersen KF, Dufour S, Befroy D, Garcia R, Shulman GI. Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes. N Engl J Med 2004;350:664-671
10. Merrill GF, Kurth EJ, Hardie DG, Winder WW. AICA riboside increases AMPactivated protein kinase, fatty acid oxidation, and glucose uptake in rat muscle. Am J Physiol 1997;273:E1107-E1112
11. Narkar VA, Downes M, Yu RT, et al. AMPK and PPARdelta agonists are exercise mimetics. Cell 2008;134:405-415
12. Milne JC, Lambert PD, Schenk S, et al. Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes. Nature 2007;450:712-716 (Pubitemid 350207685)
13. Bruce CR, Hoy AJ, Turner N, et al. Overexpression of carnitine palmitoyltransferase- 1 in skeletal muscle is sufficient to enhance fatty acid oxidation and improve high-fat diet-induced insulin resistance. Diabetes 2009;58:550-558
14. Chung J, Nguyen AK, Henstridge DC, et al. HSP72 protects against obesityinduced insulin resistance. Proc Natl Acad Sci U S A 2008;105:1739-1744 (Pubitemid 351346584)
15. Gupte AA, Bomhoff GL, Swerdlow RH, Geiger PC. Heat treatment improves glucose tolerance and prevents skeletal muscle insulin resistance in rats fed a high-fat diet. Diabetes 2009;58:567-578
16. Morino S, Kondo T, Sasaki K, et al. Mild electrical stimulation with heat shock ameliorates insulin resistance via enhanced insulin signaling. PLoS One 2008;3:e4068
17. Hirosumi J, Tuncman G, Chang L, et al. A central role for JNK in obesity and insulin resistance. Nature 2002;420:333-336 (Pubitemid 35398190)
18. Liu CT, Brooks GA. Mild heat stress induces mitochondrial biogenesis in C2C12 myotubes. J Appl Physiol (1985) 2012;112:354-361
19. Bruce CR, Carey AL, Hawley JA, Febbraio MA. Intramuscular heat shock protein 72 and heme oxygenase-1 mRNA are reduced in patients with type 2 diabetes: evidence that insulin resistance is associated with a disturbed antioxidant defense mechanism. Diabetes 2003;52:2338-2345 (Pubitemid 37059505)
20. Literáti-Nagy B, Kulcsár E, Literáti-Nagy Z, et al. Improvement of insulin sensitivity by a novel drug, BGP-15, in insulin-resistant patients: a proof of concept randomized double-blind clinical trial. Horm Metab Res 2009;41:374-380
21. Matthews VB, Allen TL, Risis S, et al. Interleukin-6-deficient mice develop hepatic inflammation and systemic insulin resistance. Diabetologia 2010;53: 2431-2441
22. Cooney GJ, Astbury LD, Williams PF, Caterson ID. Insulin response in individual tissues of control and gold thioglucose-obese mice in vivo with [1-14C]2- deoxyglucose. Diabetes 1987;36:152-158
23. Hom FG, Goodner CJ, Berrie MA. A [3H]2-deoxyglucose method for comparing rates of glucose metabolism and insulin responses among rat tissues in vivo. Validation of the model and the absence of an insulin effect on brain. Diabetes 1984;33:141-152
24. Bruce CR, Risis S, Babb JR, et al. The sphingosine-1-phosphate analog FTY720 reduces muscle ceramide content and improves glucose tolerance in high fat-fed male mice. Endocrinology 2013;154:65-76
25. Bruce CR, Dyck DJ. Cytokine regulation of skeletal muscle fatty acid metabolism: effect of interleukin-6 and tumor necrosis factor-alpha. Am J Physiol Endocrinol Metab 2004;287:E616-E621 (Pubitemid 39237888)
26. Bruce CR, Risis S, Babb JR, et al. Overexpression of sphingosine kinase 1 prevents ceramide accumulation and ameliorates muscle insulin resistance in high-fat diet-fed mice. Diabetes 2012;61:3148-3155
27. McGee SL, Sadli N, Morrison S, Swinton C, Suphioglu C. DHA protects against zinc mediated alterations in neuronal cellular bioenergetics. Cell Physiol Biochem 2011;28:157-162
28. Lee-Young RS, Griffee SR, Lynes SE, et al. Skeletal muscle AMP-activated protein kinase is essential for the metabolic response to exercise in vivo. J Biol Chem 2009;284:23925-23934
29. Kim JK, Fillmore JJ, Sunshine MJ, et al. PKC-theta knockout mice are protected from fat-induced insulin resistance. J Clin Invest 2004;114:823-827 (Pubitemid 39578741)
30. Koves TR, Ussher JR, Noland RC, et al. Mitochondrial overload and incomplete fatty acid oxidation contribute to skeletal muscle insulin resistance. Cell Metab 2008;7:45-56
31. Lin J, Handschin C, Spiegelman BM. Metabolic control through the PGC-1 family of transcription coactivators. Cell Metab 2005;1:361-370 (Pubitemid 43960626)
32. Handschin C, Spiegelman BM. The role of exercise and PGC1alpha in inflammation and chronic disease. Nature 2008;454:463-469
33. Jäger S, Handschin C, St-Pierre J, Spiegelman BM. AMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC- 1alpha. Proc Natl Acad Sci U S A 2007;104:12017-12022 (Pubitemid 47185622)
34. Kahn BB, Alquier T, Carling D, Hardie DG. AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism. Cell Metab 2005;1:15-25 (Pubitemid 43960587)
35. Feige JN, Lagouge M, Canto C, et al. Specific SIRT1 activation mimics low energy levels and protects against diet-induced metabolic disorders by enhancing fat oxidation. Cell Metab 2008;8:347-358
36. Ruderman NB, Xu XJ, Nelson L, et al. AMPK and SIRT1: a long-standing partnership? Am J Physiol Endocrinol Metab 2010;298:E751-E760
37. Rodgers JT, Lerin C, Haas W, Gygi SP, Spiegelman BM, Puigserver P. Nutrient control of glucose homeostasis through a complex of PGC-1alpha and SIRT1. Nature 2005;434:113-118 (Pubitemid 40349395)
38. Hoshino A, Mita Y, Okawa Y, et al. Cytosolic p53 inhibits Parkin-mediated mitophagy and promotes mitochondrial dysfunction in the mouse heart. Nat Commun 2013;4:2308
39. Palmer CS, Osellame LD, Stojanovski D, Ryan MT. The regulation of mitochondrial morphology: intricate mechanisms and dynamic machinery. Cell Signal 2011;23:1534-1545
40. Goto Y, Kakizaki M, Masaki N. Production of spontaneous diabetic rats by repetition of selective breeding. Tohoku J Exp Med 1976;119:85-90
41. Young JC, Hoogenraad NJ, Hartl FU. Molecular chaperones Hsp90 and Hsp70 deliver preproteins to the mitochondrial import receptor Tom70. Cell 2003; 112:41-50 (Pubitemid 36106417)
42. Leick L, Wojtaszewski JF, Johansen ST, et al. PGC-1alpha is not mandatory for exercise- and training-induced adaptive gene responses in mouse skeletal muscle. Am J Physiol Endocrinol Metab 2008;294:E463-E474 (Pubitemid 351231475)
43. Rowe GC, El-Khoury R, Patten IS, Rustin P, Arany Z. PGC-1a is dispensable for exercise-induced mitochondrial biogenesis in skeletal muscle. PLoS One 2012;7:e41817
44. Morino K, Petersen KF, Sono S, et al. Regulation of mitochondrial biogenesis by lipoprotein lipase in muscle of insulin-resistant offspring of parents with type 2 diabetes. Diabetes 2012;61:877-887
45. Holloszy JO. Skeletal muscle "mitochondrial deficiency" does not mediate insulin resistance. Am J Clin Nutr 2009;89:463S-466S
46. Becker R, Laube H, Linn T, Damian MS. Insulin resistance in patients with the mitochondrial tRNA(Leu(UUR)) gene mutation at position 3243. Exp Clin Endocrinol Diabetes 2002;110:291-297 (Pubitemid 35246746)
47. Reardon W, Ross RJ, Sweeney MG, et al. Diabetes mellitus associated with a pathogenic point mutation in mitochondrial DNA. Lancet 1992;340:1376-1379
48. Becker R, Laube H, Laube H, Linn T, Pabst W, Damian MS. Impaired glucose effectiveness in chronic progressive external ophthalmoplegia. Metabolism 2002;51:796-800 (Pubitemid 34624851)
49. Linnane AW, Marzuki S, Ozawa T, Tanaka M. Mitochondrial DNA mutations as an important contributor to ageing and degenerative diseases. Lancet 1989;1: 642-645 (Pubitemid 19078788)
50. Trounce I, Byrne E, Marzuki S. Decline in skeletal muscle mitochondrial respiratory chain function: possible factor in ageing. Lancet 1989;1:637-639 (Pubitemid 19078786)
51. Boffoli D, Scacco SC, Vergari R, Solarino G, Santacroce G, Papa S. Decline with age of the respiratory chain activity in human skeletal muscle. Biochim Biophys Acta 1994;1226:73-82 (Pubitemid 24123058)
52. Cooper JM, Mann VM, Schapira AH. Analyses of mitochondrial respiratory chain function and mitochondrial DNA deletion in human skeletal muscle: effect of ageing. J Neurol Sci 1992;113:91-98
53. Safdar A, Bourgeois JM, Ogborn DI, et al. Endurance exercise rescues progeroid aging and induces systemic mitochondrial rejuvenation in mtDNA mutator mice. Proc Natl Acad Sci U S A 2011;108:4135-4140
54. Kuznetsov AV, Winkler K, Wiedemann FR, von Bossanyi P, Dietzmann K, Kunz WS. Impaired mitochondrial oxidative phosphorylation in skeletal muscle of the dystrophin-deficient mdx mouse. Mol Cell Biochem 1998;183:87-96 (Pubitemid 28263891)
55. Millay DP, Sargent MA, Osinska H, et al. Genetic and pharmacologic inhibition of mitochondrial-dependent necrosis attenuates muscular dystrophy. Nat Med 2008;14:442-447 (Pubitemid 351499389)
56. Gehrig SM, van der Poel C, Sayer TA, et al. Hsp72 preserves muscle function and slows progression of severe muscular dystrophy. Nature 2012;484: 394-398